Resectie van levermetastasen bij borstkanker: Stand van zaken

Translated title of the contribution: Resection of liver metastases in breast cancer

Aldrick Ruiz, Dennis Wicherts, René Adam, Sabine Siesling, Sabine Linn, Richard Van Hillegersberg*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)

Abstract

Liver metastases have the poorest prognosis of all types of breast cancer metastases, with a 5year survival rate of 0 to 12%. In comparison, the 5year overall survival rate of patients with colorectal liver metastases undergoing curative liver resection is approximately 30 to 40% and even 50% in selected patients. Partial liver resection in combination with systemic treatment for patients with hepatogenic metastases from breast cancer may lead to improved survival rates for selected patients.

Translated title of the contributionResection of liver metastases in breast cancer
Original languageDutch
Article numberA8453
JournalNederlands tijdschrift voor geneeskunde
Volume159
Issue number31
Publication statusPublished - 1 Jan 2015

Fingerprint Dive into the research topics of 'Resection of liver metastases in breast cancer: Stand van zaken'. Together they form a unique fingerprint.

Cite this